Fig. 7From: YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axisYY1 promotes metastasis and cell cycle progression and inhibits apoptosis in bile duct cancer cells through EMI2. A, B Transwell assay was used to verify the changes in invasion and migration in each group; C, D A wound-healing assay was performed to detect the changes in cell mobility in each group; E The changes in apoptosis in each group were detected using Annexin-v APC; F Cell cycle changes in each group were detected using flow cytometry (*P < 0.05; **P < 0.01; ***P < 0.001)Back to article page